Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Scott E. Eggener

Concepts (555)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
161
2020
1385
28.710
Why?
Prostatectomy
63
2019
417
12.890
Why?
Testicular Neoplasms
28
2020
103
12.410
Why?
Prostate-Specific Antigen
43
2020
303
10.470
Why?
Neoplasms, Germ Cell and Embryonal
14
2020
38
7.150
Why?
Kidney Neoplasms
34
2019
557
6.550
Why?
Lymph Node Excision
18
2020
211
6.190
Why?
Prostate
30
2019
237
6.060
Why?
Nephrectomy
31
2019
292
5.750
Why?
Watchful Waiting
12
2019
44
4.950
Why?
Male
243
2020
40438
4.350
Why?
Carcinoma, Renal Cell
19
2019
367
4.080
Why?
Early Detection of Cancer
13
2020
286
3.490
Why?
Magnetic Resonance Imaging, Interventional
9
2020
31
3.450
Why?
Neoplasm Grading
22
2020
310
3.410
Why?
Humans
263
2020
78870
3.210
Why?
Neoplasm Staging
52
2020
1908
3.100
Why?
Laser Therapy
12
2020
153
2.800
Why?
Neoplasm Recurrence, Local
19
2020
1158
2.720
Why?
Urinary Incontinence
9
2017
120
2.710
Why?
Population Surveillance
7
2019
241
2.570
Why?
Laparoscopy
20
2018
681
2.570
Why?
Retroperitoneal Space
10
2020
38
2.470
Why?
Aged
107
2020
17853
2.440
Why?
Middle Aged
122
2020
24751
2.300
Why?
Seminoma
3
2018
13
2.220
Why?
Ablation Techniques
5
2019
37
2.160
Why?
Magnetic Resonance Imaging
32
2020
3119
2.130
Why?
SEER Program
9
2020
192
2.100
Why?
Lymph Nodes
7
2019
522
2.050
Why?
Biopsy
27
2019
1137
2.050
Why?
Life Expectancy
4
2017
82
2.010
Why?
Orchiectomy
10
2018
64
1.960
Why?
Prognosis
36
2020
3569
1.940
Why?
Mass Screening
8
2019
609
1.850
Why?
Retrospective Studies
53
2019
6967
1.780
Why?
Organ Transplantation
4
2020
258
1.770
Why?
Chemotherapy, Adjuvant
6
2020
482
1.710
Why?
Retroperitoneal Neoplasms
5
2018
57
1.700
Why?
Teratoma
5
2018
45
1.650
Why?
Disease Management
5
2019
316
1.570
Why?
Robotics
12
2015
243
1.560
Why?
Photochemotherapy
7
2018
97
1.550
Why?
United States
31
2020
5931
1.550
Why?
Consensus
11
2020
271
1.530
Why?
Lymphatic Metastasis
16
2020
502
1.530
Why?
Treatment Outcome
45
2020
7557
1.490
Why?
Kallikreins
7
2020
38
1.490
Why?
Biopsy, Needle
14
2014
268
1.480
Why?
Patient Selection
12
2019
675
1.450
Why?
Practice Guidelines as Topic
7
2019
1073
1.380
Why?
Adenocarcinoma
4
2016
1228
1.350
Why?
Warm Ischemia
5
2014
27
1.320
Why?
Cryosurgery
7
2018
41
1.310
Why?
Radiotherapy, Adjuvant
6
2017
303
1.260
Why?
Quality of Life
9
2019
1230
1.180
Why?
Risk Factors
24
2020
5153
1.180
Why?
Ultrasound, High-Intensity Focused, Transrectal
5
2012
5
1.170
Why?
High-Intensity Focused Ultrasound Ablation
4
2020
24
1.160
Why?
Salvage Therapy
6
2017
218
1.140
Why?
Adult
56
2020
24973
1.140
Why?
Risk Assessment
27
2019
2174
1.110
Why?
Surgery, Computer-Assisted
5
2018
107
1.110
Why?
Epididymis
6
2018
22
1.080
Why?
Combined Modality Therapy
13
2020
1648
1.050
Why?
Incidence
15
2018
1560
1.040
Why?
Predictive Value of Tests
22
2018
1651
1.020
Why?
Disease-Free Survival
14
2018
1206
0.980
Why?
Neoplasm Invasiveness
13
2016
527
0.970
Why?
Kidney
9
2018
1198
0.960
Why?
Cohort Studies
19
2020
2555
0.950
Why?
Erectile Dysfunction
3
2014
87
0.950
Why?
Urinary Bladder Neoplasms
9
2011
316
0.950
Why?
Aged, 80 and over
24
2020
6389
0.940
Why?
Postoperative Complications
9
2020
2215
0.920
Why?
Glomerular Filtration Rate
8
2014
359
0.920
Why?
Tumor Burden
6
2018
273
0.880
Why?
Proportional Hazards Models
12
2017
854
0.860
Why?
Prospective Studies
20
2020
3795
0.850
Why?
Induction Chemotherapy
1
2020
116
0.820
Why?
Age Factors
13
2017
1874
0.820
Why?
Genes, Neoplasm
1
2019
41
0.810
Why?
Lost to Follow-Up
1
2018
12
0.800
Why?
Rectum
3
2018
179
0.800
Why?
Aorta, Abdominal
1
2018
60
0.780
Why?
Clinical Protocols
2
2019
154
0.770
Why?
Intraoperative Complications
2
2018
187
0.770
Why?
Insurance, Health
2
2017
138
0.770
Why?
Guideline Adherence
3
2016
220
0.750
Why?
Multivariate Analysis
14
2018
1010
0.750
Why?
Carcinoma, Transitional Cell
6
2012
141
0.740
Why?
Acinar Cells
1
2017
7
0.730
Why?
Time Factors
22
2018
5368
0.720
Why?
Postoperative Hemorrhage
2
2016
51
0.720
Why?
Logistic Models
9
2016
1130
0.720
Why?
alpha-Fetoproteins
1
2017
41
0.710
Why?
Vena Cava, Inferior
1
2018
138
0.690
Why?
Medicare
2
2020
227
0.690
Why?
Public Policy
1
2016
51
0.680
Why?
Cold Ischemia
2
2014
18
0.680
Why?
African Americans
5
2018
1102
0.660
Why?
Seminal Vesicles
4
2017
32
0.660
Why?
Androgen Antagonists
2
2014
100
0.650
Why?
Anti-Bacterial Agents
2
2013
757
0.640
Why?
Carcinoma, Ductal
1
2015
17
0.640
Why?
Carcinoma, Acinar Cell
1
2015
13
0.640
Why?
Medically Uninsured
1
2015
53
0.640
Why?
Aspirin
1
2016
129
0.630
Why?
Survival Rate
11
2015
1901
0.630
Why?
Platelet Aggregation Inhibitors
1
2016
104
0.630
Why?
Cost-Benefit Analysis
1
2017
389
0.620
Why?
Young Adult
12
2020
5628
0.610
Why?
Health Policy
1
2016
162
0.610
Why?
Goserelin
1
2014
7
0.610
Why?
Tosyl Compounds
1
2014
15
0.600
Why?
Urology
4
2017
79
0.600
Why?
Carboplatin
1
2015
246
0.590
Why?
Nitriles
1
2014
86
0.580
Why?
Contrast Media
12
2019
1044
0.580
Why?
Immunosuppressive Agents
1
2020
1007
0.580
Why?
Anilides
1
2014
48
0.580
Why?
Gonadotropin-Releasing Hormone
1
2014
94
0.570
Why?
Kidney Diseases
3
2010
418
0.570
Why?
Intestinal Diseases
1
2014
80
0.550
Why?
Ciprofloxacin
1
2013
57
0.550
Why?
Brachytherapy
5
2017
103
0.540
Why?
Databases, Factual
6
2016
782
0.520
Why?
Nomograms
3
2011
24
0.520
Why?
Expert Testimony
3
2020
49
0.510
Why?
Developed Countries
1
2012
24
0.510
Why?
Survival Analysis
13
2019
1570
0.510
Why?
Developing Countries
1
2012
70
0.490
Why?
Europe
4
2020
300
0.490
Why?
Androgens
4
2018
147
0.470
Why?
Sensitivity and Specificity
12
2019
2081
0.470
Why?
Clinical Trials as Topic
5
2019
1162
0.460
Why?
Epithelial Cells
5
2018
599
0.450
Why?
Forecasting
3
2019
307
0.440
Why?
Finasteride
2
2009
10
0.440
Why?
Female
41
2019
42913
0.440
Why?
Sentinel Surveillance
1
2009
26
0.430
Why?
Follow-Up Studies
14
2019
3735
0.420
Why?
Kidney Tubules, Collecting
1
2009
25
0.420
Why?
Sus scrofa
1
2009
45
0.420
Why?
Environmental Exposure
1
2012
255
0.420
Why?
Treatment Failure
2
2014
299
0.410
Why?
5-alpha Reductase Inhibitors
1
2009
8
0.410
Why?
Systems Theory
1
2009
3
0.410
Why?
Bucrylate
1
2008
3
0.410
Why?
Sutures
1
2009
48
0.410
Why?
Gadolinium DTPA
7
2014
265
0.400
Why?
Tissue Adhesives
1
2008
24
0.400
Why?
Disease Progression
10
2018
1406
0.400
Why?
Chemoprevention
1
2009
86
0.400
Why?
Hospitalization
1
2014
709
0.390
Why?
Feasibility Studies
5
2019
711
0.390
Why?
Research Design
3
2019
549
0.390
Why?
Decision Making
1
2014
609
0.370
Why?
Enzyme Inhibitors
2
2009
670
0.370
Why?
Tomography, X-Ray Computed
8
2019
2548
0.370
Why?
Image Enhancement
4
2018
585
0.360
Why?
Diffusion Magnetic Resonance Imaging
6
2019
226
0.360
Why?
Ultrasonography, Interventional
4
2018
115
0.360
Why?
Ureteral Neoplasms
3
2012
16
0.360
Why?
Penile Erection
2
2017
35
0.360
Why?
Neoplasm, Residual
5
2018
131
0.360
Why?
Kaplan-Meier Estimate
4
2019
909
0.360
Why?
Odds Ratio
3
2017
685
0.350
Why?
Nuclear Proteins
2
2014
685
0.340
Why?
Neoplasms
1
2020
2498
0.330
Why?
Radiotherapy, Intensity-Modulated
2
2019
161
0.330
Why?
Perioperative Care
2
2019
146
0.320
Why?
Cryptorchidism
1
2005
12
0.320
Why?
Genital Neoplasms, Male
1
2005
10
0.320
Why?
Kidney Failure, Chronic
1
2010
502
0.310
Why?
Blood Loss, Surgical
2
2016
107
0.310
Why?
Neoplasm Metastasis
8
2014
1024
0.310
Why?
Genetic Testing
2
2020
481
0.300
Why?
Comorbidity
3
2019
877
0.300
Why?
Sarcoma, Myeloid
1
2004
13
0.290
Why?
Vascular Neoplasms
1
2004
17
0.290
Why?
Kidney Function Tests
4
2013
130
0.290
Why?
Fructose
1
2004
33
0.290
Why?
Electrochemotherapy
3
2018
4
0.280
Why?
Emphysema
1
2003
14
0.280
Why?
Registries
3
2019
593
0.280
Why?
Urinary Calculi
1
2004
67
0.280
Why?
Length of Stay
3
2016
656
0.280
Why?
Image Interpretation, Computer-Assisted
5
2018
675
0.270
Why?
Chemoembolization, Therapeutic
1
2003
29
0.270
Why?
Radiotherapy
2
2016
341
0.270
Why?
Analysis of Variance
6
2014
954
0.270
Why?
Preoperative Care
5
2019
408
0.270
Why?
Risk
2
2015
690
0.270
Why?
Penis
1
2003
81
0.260
Why?
Anticonvulsants
1
2004
115
0.260
Why?
Health Surveys
2
2015
242
0.260
Why?
Magnetic Resonance Angiography
1
2005
244
0.260
Why?
Delphi Technique
3
2019
60
0.250
Why?
False Positive Reactions
2
2015
241
0.250
Why?
Antineoplastic Agents
5
2019
2324
0.250
Why?
Magnetic Resonance Spectroscopy
2
2014
313
0.250
Why?
Pulmonary Artery
1
2004
290
0.250
Why?
Lipoma
1
2001
25
0.250
Why?
Cause of Death
2
2014
266
0.250
Why?
Primary Cell Culture
3
2018
65
0.240
Why?
Pulmonary Embolism
1
2004
187
0.240
Why?
Receptors, Androgen
2
2018
89
0.240
Why?
Hydronephrosis
2
2011
28
0.240
Why?
Ureteroscopy
2
2012
51
0.230
Why?
Urinary Bladder
3
2015
172
0.230
Why?
Pelvis
3
2019
77
0.220
Why?
Body Mass Index
2
2014
727
0.220
Why?
Canada
1
2020
197
0.220
Why?
Gene Regulatory Networks
3
2018
270
0.220
Why?
Interdisciplinary Studies
1
2019
21
0.220
Why?
Propensity Score
1
2020
128
0.220
Why?
Adolescent
7
2017
8787
0.210
Why?
Pathology, Molecular
1
2019
32
0.210
Why?
Prostatic Hyperplasia
2
2018
95
0.210
Why?
Venae Cavae
1
2019
16
0.210
Why?
Hyperthermia, Induced
1
2020
73
0.210
Why?
Jordan
1
2018
2
0.210
Why?
Urinalysis
1
2019
45
0.210
Why?
United States Food and Drug Administration
1
2019
115
0.200
Why?
Patients
1
2019
87
0.200
Why?
Linear Models
4
2014
424
0.200
Why?
Dissection
2
2017
47
0.200
Why?
Quality Improvement
2
2019
332
0.200
Why?
Music Therapy
1
2018
4
0.200
Why?
Journalism, Medical
1
1998
7
0.200
Why?
Ultrasonography
2
2013
673
0.190
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2018
15
0.190
Why?
Cross-Sectional Studies
2
2014
1316
0.190
Why?
Gadolinium
1
2018
99
0.190
Why?
Employment
1
1998
48
0.190
Why?
Immunohistochemistry
7
2013
1804
0.190
Why?
Animals
10
2014
26141
0.190
Why?
Pelvic Neoplasms
1
2017
45
0.190
Why?
Transplantation Conditioning
1
2020
363
0.190
Why?
Radiation Injuries
1
2019
161
0.190
Why?
Germ-Line Mutation
1
2020
269
0.180
Why?
Hematologic Neoplasms
1
2020
281
0.180
Why?
Models, Educational
1
2017
50
0.180
Why?
Decision Support Techniques
1
2019
152
0.180
Why?
Clinical Trials, Phase II as Topic
1
2018
169
0.180
Why?
Urination Disorders
2
2015
38
0.180
Why?
Vascular Surgical Procedures
1
2018
155
0.180
Why?
Monitoring, Physiologic
2
2009
275
0.180
Why?
Clinical Trials, Phase I as Topic
1
2018
153
0.170
Why?
Urination
1
2016
32
0.170
Why?
Positron-Emission Tomography
1
2018
273
0.170
Why?
Venous Thrombosis
1
2019
207
0.170
Why?
Hepatocyte Nuclear Factor 1
1
2016
30
0.170
Why?
Societies, Medical
2
2017
505
0.170
Why?
Device Approval
1
2015
11
0.170
Why?
Anxiety
1
2018
232
0.160
Why?
Testis
1
2016
171
0.160
Why?
Regulatory Elements, Transcriptional
1
2016
44
0.160
Why?
RNA, Messenger
3
2019
1969
0.160
Why?
Cystadenoma
1
2015
17
0.160
Why?
Melanoma
1
2020
478
0.160
Why?
Spermatozoa
1
2015
68
0.160
Why?
Selection Bias
1
2015
38
0.160
Why?
Creatinine
2
2014
328
0.160
Why?
Blood Transfusion
1
2016
141
0.160
Why?
Statistics, Nonparametric
2
2013
320
0.150
Why?
Probability
3
2013
350
0.150
Why?
Protein Precursors
1
2015
148
0.150
Why?
Hysterectomy
1
2015
82
0.150
Why?
Child
3
2020
6404
0.150
Why?
Serine Endopeptidases
1
2015
174
0.150
Why?
Technology Assessment, Biomedical
1
2014
31
0.150
Why?
Gene Expression Regulation, Neoplastic
4
2008
1192
0.150
Why?
Trans-Activators
2
2015
433
0.150
Why?
Organ Sparing Treatments
1
2014
34
0.140
Why?
Anatomic Landmarks
1
2014
32
0.140
Why?
Genomics
2
2019
576
0.140
Why?
Mental Recall
1
2015
126
0.140
Why?
MicroRNAs
1
2018
473
0.140
Why?
Sex Factors
2
2015
1060
0.140
Why?
Immunity, Innate
1
2018
393
0.140
Why?
Carrier Proteins
2
2008
679
0.140
Why?
Interviews as Topic
1
2015
330
0.140
Why?
Lymphocele
1
2013
5
0.140
Why?
Antigens, Neoplasm
1
2015
296
0.140
Why?
Peripheral Nerve Injuries
1
2013
9
0.140
Why?
Carcinoma, Small Cell
1
2014
142
0.140
Why?
Social Media
1
2014
54
0.140
Why?
Mortality
1
2014
142
0.140
Why?
Mannitol
1
2012
50
0.130
Why?
Activities of Daily Living
1
2014
183
0.130
Why?
Healthcare Disparities
1
2017
305
0.130
Why?
Confidence Intervals
2
2013
235
0.130
Why?
Algorithms
4
2019
1813
0.130
Why?
Image Processing, Computer-Assisted
1
2019
1169
0.130
Why?
Monte Carlo Method
1
2013
165
0.130
Why?
ROC Curve
4
2018
773
0.130
Why?
Cell Proliferation
2
2017
1573
0.130
Why?
Equipment Design
1
2013
418
0.130
Why?
Reoperation
2
2018
602
0.120
Why?
Advisory Committees
1
2012
86
0.120
Why?
Continental Population Groups
1
2014
291
0.120
Why?
Urothelium
1
2012
64
0.120
Why?
Chicago
1
2016
1379
0.120
Why?
Americas
1
2011
19
0.120
Why?
Urography
2
2009
48
0.120
Why?
Cystectomy
2
2010
65
0.120
Why?
Mice, Nude
3
2014
777
0.120
Why?
Asia
1
2011
85
0.120
Why?
Africa
1
2011
96
0.120
Why?
Australia
1
2011
84
0.120
Why?
Patient Safety
1
2014
208
0.120
Why?
Health Status
1
2014
348
0.120
Why?
Physicians
1
1998
576
0.120
Why?
European Continental Ancestry Group
1
2016
1067
0.110
Why?
Neovascularization, Pathologic
2
2011
363
0.110
Why?
Depression
1
2014
384
0.110
Why?
Internship and Residency
2
2017
857
0.110
Why?
Mathematics
1
2010
192
0.110
Why?
Repressor Proteins
1
2014
388
0.110
Why?
Renal Insufficiency, Chronic
1
2014
246
0.110
Why?
Recurrence
4
2008
1147
0.110
Why?
Urinary Reservoirs, Continent
1
2010
13
0.110
Why?
Trauma, Nervous System
1
2009
4
0.110
Why?
Ejaculation
1
2009
9
0.110
Why?
Tumor Suppressor Protein p53
2
2003
361
0.110
Why?
Medical Illustration
1
2009
14
0.110
Why?
Proteins
1
2015
762
0.110
Why?
Calreticulin
1
2009
12
0.110
Why?
Urine
1
2010
104
0.110
Why?
Credentialing
1
2009
16
0.110
Why?
Urinary Diversion
1
2010
44
0.110
Why?
Smoking
1
2014
562
0.110
Why?
Postoperative Period
3
2015
294
0.110
Why?
Living Donors
1
2012
275
0.110
Why?
Diagnosis, Computer-Assisted
1
2013
358
0.100
Why?
Socioeconomic Factors
1
2012
560
0.100
Why?
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
1
2009
7
0.100
Why?
Nephrons
1
2009
19
0.100
Why?
Azasteroids
1
2009
6
0.100
Why?
Validation Studies as Topic
1
2009
14
0.100
Why?
Gene Expression Profiling
4
2018
1321
0.100
Why?
Obesity
2
2014
900
0.100
Why?
Bacteriochlorophylls
1
2008
1
0.100
Why?
Fascia
1
2009
28
0.100
Why?
Multicenter Studies as Topic
1
2009
145
0.100
Why?
Residence Characteristics
1
2011
191
0.100
Why?
Radiographic Image Enhancement
1
2012
530
0.100
Why?
Cell Line, Tumor
4
2009
2357
0.100
Why?
Proto-Oncogene Proteins c-ets
1
2008
21
0.100
Why?
Urologic Surgical Procedures
1
2009
96
0.100
Why?
Primary Prevention
1
2009
79
0.100
Why?
Neoplastic Stem Cells
1
2009
129
0.090
Why?
Prostatic Secretory Proteins
1
2007
1
0.090
Why?
Seminal Plasma Proteins
1
2007
2
0.090
Why?
Salivary Proteins and Peptides
1
2007
3
0.090
Why?
Gene Expression Regulation
4
2018
1887
0.090
Why?
Overweight
1
2008
107
0.090
Why?
Dioxygenases
1
2007
30
0.090
Why?
Gene Rearrangement
1
2008
163
0.090
Why?
Swine
1
2008
543
0.090
Why?
Radiotherapy, Conformal
1
2007
87
0.090
Why?
Chronic Disease
1
2010
931
0.090
Why?
BCG Vaccine
1
2006
17
0.090
Why?
Neoadjuvant Therapy
2
2019
264
0.090
Why?
Survival
1
2006
23
0.090
Why?
Kidney Transplantation
1
2012
800
0.080
Why?
Catheter Ablation
3
2016
305
0.080
Why?
Carcinoma in Situ
1
2006
56
0.080
Why?
Thromboembolism
1
2006
118
0.080
Why?
Reproducibility of Results
4
2014
2594
0.080
Why?
Immunocompromised Host
1
2006
136
0.080
Why?
Steroids
1
2006
166
0.080
Why?
Adjuvants, Immunologic
1
2006
153
0.080
Why?
Hematuria
2
2002
41
0.080
Why?
Evidence-Based Medicine
1
2008
434
0.080
Why?
Transplantation, Heterologous
1
2006
356
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2007
2200
0.080
Why?
Costs and Cost Analysis
1
2005
150
0.070
Why?
Cystitis
1
2004
16
0.070
Why?
Cardiovascular Diseases
1
2011
751
0.070
Why?
Kinetics
1
2007
1605
0.070
Why?
Cell Nucleolus
1
2004
24
0.070
Why?
Daunorubicin
1
2004
75
0.070
Why?
Coitus
1
2003
14
0.070
Why?
Rupture
1
2003
59
0.070
Why?
Plasma Cells
1
2004
97
0.070
Why?
Cell Cycle
1
2006
519
0.070
Why?
Referral and Consultation
1
2006
309
0.070
Why?
Cytarabine
1
2004
212
0.070
Why?
Methotrexate
1
2004
253
0.070
Why?
Paclitaxel
1
2005
438
0.070
Why?
Urinary Fistula
1
2002
9
0.070
Why?
Severity of Illness Index
1
2009
1706
0.070
Why?
Vascular Fistula
1
2002
12
0.070
Why?
Carcinoma
1
2006
434
0.070
Why?
Iliac Artery
1
2002
39
0.070
Why?
Genes, p53
1
2003
112
0.070
Why?
Fatal Outcome
1
2003
304
0.070
Why?
Abdominal Pain
1
2004
120
0.060
Why?
Diagnosis, Differential
3
2015
1592
0.060
Why?
Suture Techniques
1
2003
140
0.060
Why?
Fat Necrosis
1
2002
4
0.060
Why?
Mice
4
2014
10739
0.060
Why?
Acute Disease
1
2004
840
0.060
Why?
Colonic Diseases
1
2002
68
0.060
Why?
Seizures
1
2004
251
0.060
Why?
Chromatin
1
2004
322
0.060
Why?
Urethra
1
2002
79
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2018
916
0.060
Why?
Calcinosis
1
2002
240
0.060
Why?
Muscle, Smooth
1
2002
372
0.050
Why?
Oligonucleotide Array Sequence Analysis
3
2008
703
0.050
Why?
Radiologic Health
1
2019
2
0.050
Why?
Stents
1
2002
366
0.050
Why?
San Francisco
1
2019
19
0.050
Why?
Medical Oncology
2
2017
303
0.050
Why?
Endpoint Determination
1
2019
60
0.050
Why?
Education
1
2019
55
0.050
Why?
Cells, Cultured
2
2016
2917
0.050
Why?
Kidney Calculi
1
2003
395
0.050
Why?
CCAAT-Enhancer-Binding Protein-beta
1
2018
12
0.050
Why?
History, 20th Century
1
2020
314
0.050
Why?
Core Binding Factor Alpha 2 Subunit
1
2018
45
0.050
Why?
Unnecessary Procedures
1
2019
43
0.050
Why?
Disease Susceptibility
1
2019
167
0.050
Why?
Mexico
1
2018
62
0.050
Why?
Leukemia, Myeloid, Acute
1
2004
623
0.050
Why?
PAX2 Transcription Factor
1
2018
6
0.050
Why?
Ploidies
1
2018
46
0.050
Why?
Toll-Like Receptor 3
1
2018
7
0.050
Why?
Poly I-C
1
2018
15
0.050
Why?
Career Mobility
1
1998
29
0.050
Why?
Intention to Treat Analysis
1
2018
66
0.050
Why?
Heredity
1
2017
17
0.050
Why?
Quality Control
1
2018
125
0.050
Why?
Cell Line
2
2018
2588
0.050
Why?
Radiation Oncology
1
2019
105
0.050
Why?
Epithelium
1
2018
314
0.050
Why?
Sequence Analysis, RNA
1
2018
182
0.040
Why?
Patient Preference
1
2018
96
0.040
Why?
In Situ Hybridization, Fluorescence
1
2018
362
0.040
Why?
Cell Transformation, Neoplastic
2
2014
411
0.040
Why?
Recovery of Function
2
2010
257
0.040
Why?
Controlled Clinical Trials as Topic
1
2016
26
0.040
Why?
Age of Onset
1
2017
308
0.040
Why?
Clinical Competence
2
2015
674
0.040
Why?
Pain Measurement
1
2018
292
0.040
Why?
Career Choice
1
1998
130
0.040
Why?
Ligands
1
2018
410
0.040
Why?
Social Behavior
1
2019
276
0.040
Why?
Molecular Targeted Therapy
1
2019
260
0.040
Why?
Sperm Maturation
1
2015
2
0.040
Why?
Anti-Inflammatory Agents
2
2012
335
0.040
Why?
Psychiatric Status Rating Scales
1
2018
444
0.040
Why?
Pilot Projects
1
2018
790
0.040
Why?
Self Report
1
2017
247
0.040
Why?
Xenograft Model Antitumor Assays
2
2009
449
0.040
Why?
Chromatin Immunoprecipitation
1
2016
132
0.040
Why?
Preoperative Period
1
2015
82
0.040
Why?
Molecular Sequence Annotation
1
2015
72
0.040
Why?
Learning Curve
1
2015
17
0.040
Why?
Keratin-8
1
2014
1
0.040
Why?
Pedigree
1
2017
1000
0.040
Why?
Clusterin
1
2014
14
0.040
Why?
Organ Specificity
1
2015
255
0.040
Why?
London
1
2014
15
0.040
Why?
Diagnostic Imaging
1
2019
438
0.040
Why?
Forearm
1
1994
33
0.040
Why?
HIV Infections
1
2003
684
0.040
Why?
Cell Membrane Permeability
1
2014
132
0.040
Why?
Cryotherapy
1
2014
33
0.040
Why?
Ultrasonic Therapy
1
2014
26
0.040
Why?
Cell Polarity
1
2014
120
0.040
Why?
Electroporation
1
2014
63
0.040
Why?
Computer Simulation
1
2018
1022
0.040
Why?
Ubiquitination
1
2014
79
0.040
Why?
Apoptosis
3
2007
1751
0.030
Why?
Critical Pathways
1
2013
34
0.030
Why?
Models, Anatomic
1
2013
93
0.030
Why?
Discriminant Analysis
1
2013
62
0.030
Why?
Gene Knockdown Techniques
1
2014
231
0.030
Why?
Nitric Oxide
1
1994
266
0.030
Why?
Ubiquitin-Protein Ligases
1
2014
158
0.030
Why?
Checklist
1
2013
50
0.030
Why?
Internationality
1
2012
68
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
396
0.030
Why?
Postoperative Care
1
2013
234
0.030
Why?
Membrane Glycoproteins
1
2014
422
0.030
Why?
Computational Biology
1
2016
510
0.030
Why?
Area Under Curve
1
2013
341
0.030
Why?
Observer Variation
1
2014
654
0.030
Why?
Muscles
1
2012
187
0.030
Why?
HEK293 Cells
1
2014
597
0.030
Why?
Health Care Surveys
1
2012
301
0.030
Why?
Patient Discharge
1
2013
197
0.030
Why?
Attitude of Health Personnel
1
2017
637
0.030
Why?
Tissue Culture Techniques
1
2011
77
0.030
Why?
Antioxidants
1
2012
228
0.030
Why?
Immunoenzyme Techniques
1
2011
329
0.030
Why?
Phenotype
1
2017
2183
0.030
Why?
Mice, Inbred BALB C
1
2014
1057
0.030
Why?
Cytodiagnosis
1
2011
44
0.030
Why?
Stress, Psychological
1
1994
302
0.030
Why?
Ureter
1
2011
91
0.030
Why?
Transcription, Genetic
1
2016
1157
0.030
Why?
Constriction
1
2009
24
0.030
Why?
Fibrosis
1
2010
174
0.030
Why?
Chi-Square Distribution
1
2010
385
0.030
Why?
Digital Rectal Examination
1
2008
5
0.030
Why?
Observation
1
2008
37
0.020
Why?
Cell Differentiation
1
2015
1435
0.020
Why?
Trypsin Inhibitor, Kazal Pancreatic
1
2008
5
0.020
Why?
Education, Medical, Continuing
1
2009
99
0.020
Why?
Gene Fusion
1
2008
30
0.020
Why?
Genetic Predisposition to Disease
1
2017
2122
0.020
Why?
Tissue Array Analysis
1
2008
130
0.020
Why?
Dose-Response Relationship, Drug
1
2012
2074
0.020
Why?
Down-Regulation
1
2009
514
0.020
Why?
Sexual Dysfunction, Physiological
1
2007
51
0.020
Why?
Metals
1
2007
89
0.020
Why?
Lung Diseases
1
2009
280
0.020
Why?
Protein Structure, Tertiary
1
2009
764
0.020
Why?
Administration, Intravesical
1
2006
21
0.020
Why?
RNA Interference
1
2008
375
0.020
Why?
Transfection
1
2008
942
0.020
Why?
RNA, Small Interfering
1
2008
571
0.020
Why?
Education, Medical, Graduate
1
2009
316
0.020
Why?
Mutation
2
2009
3708
0.020
Why?
Neoplasm Transplantation
1
2005
402
0.020
Why?
Cystitis, Interstitial
1
2004
32
0.020
Why?
Eosinophilia
1
2004
78
0.020
Why?
Prednisone
1
2004
260
0.020
Why?
Models, Biological
1
2011
1755
0.020
Why?
Neoplasms, Experimental
1
2005
283
0.020
Why?
Protein Binding
1
2007
1465
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2005
298
0.020
Why?
Urologic Surgical Procedures, Male
1
2002
17
0.020
Why?
Shock
1
2002
39
0.020
Why?
Signal Transduction
1
2014
3233
0.020
Why?
Cell Survival
1
2005
1006
0.020
Why?
Gene Silencing
1
2003
181
0.020
Why?
Rats
1
2009
4309
0.020
Why?
Autopsy
1
2002
114
0.020
Why?
DNA-Binding Proteins
1
2008
1175
0.010
Why?
Terminology as Topic
1
2002
205
0.010
Why?
Uterine Cervical Neoplasms
1
2002
235
0.010
Why?
Transcription Factors
1
2008
1471
0.010
Why?
omega-N-Methylarginine
1
1994
18
0.010
Why?
Atropine
1
1994
62
0.010
Why?
Vasodilation
1
1994
98
0.010
Why?
Arginine
1
1994
133
0.010
Why?
Regional Blood Flow
1
1994
199
0.010
Why?
Blood Flow Velocity
1
1994
197
0.010
Why?
Eggener's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_